N-((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxamideor Siponimod impurity 13^7

The catalog number for N-((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxamideor Siponimod impurity 13^7 is TRC-C295900-10MG.

N-((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxamideor Siponimod impurity 13^7 is available in the following size(s): 10 mg.

N-((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxamideor Siponimod impurity 13^7 is currently made to order / not held in immediate stock. Contact us for lead time.

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.